YX-2-107
YX-2-107 is a PROTAC (IC50= 4.4 nM) that selectively degrades CDK6. YX-2-107 effectively inhibits RB phosphorylation and FOXM1 expression in vitro and inhibits the development of Ph+ ALL in rats. YX-2-107 can be used in the study of Ph chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) [1].
Product Specifications
CAS Number
2417408-46-7
UNSPSC
12352005
Target
CDK; PROTACs
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/yx-2-107.html
Purity
98.60
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1NC(C(CC1)N2C(C3=C(C2=O)C(OCC(NCCCCNCC(N4CCN(CC4)C5=CN=C(NC6=NC(N(C7CCCC7)C(C(C(C)=O)=C8C)=O)=C8C=N6)C=C5)=O)=O)=CC=C3)=O)=O
Molecular Formula
C45H51N11O9
Molecular Weight
889.95
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK6
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human PIIINP (N-Terminal Procollagen III Propeptide) CLIA Kit
Human PIIINP (N-Terminal Procollagen III Propeptide) CLIA Kit
Human PIIINP (N-Terminal Procollagen III Propeptide) CLIA Kit
Apc11 (ANAPC11) (NM_001002244) Human Over-expression Lysate
